Zhang T Y, Sun X, Yao Y H, Jin Q, Gan D N, Ye Y A, Li X K
Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China Liver Diseases Academy of TCM, Beijing University of Chinese Medicine, Beijing 100700, China.
Zhonghua Gan Zang Bing Za Zhi. 2023 Sep 20;31(9):921-927. doi: 10.3760/cma.j.cn501113-20221111-00560.
The European Association for the Study of Liver Diseases issued the "Clinical Practice Guidelines for the Management of Hepatic Encephalopathy" in 2022, which included recommendations for clinical diagnosis, assessment, treatment, management, and prevention. The Society's "Hepatic Encephalopathy Clinical Practice Guidelines in Chronic Liver Disease," which was last published in 2014, and the "Guidelines for the Diagnosis and Treatment of Hepatic Encephalopathy in Cirrhosis," which the Chinese Society of Hepatology, Chinese Medical Association, released in 2018, have certain differences and updates in terms of comparison to terminology, grading and classification, diagnosis, clinical evaluation and treatment, management, and prevention. Herein, the updated points of this guideline and the differences between it and our nation's guidelines are summarized in order to refine and understand the guiding role of the new version of the guideline for the clinical treatment of hepatic encephalopathy and provide aid for standardizing clinical diagnosis and treatment.
欧洲肝脏研究协会于2022年发布了《肝性脑病管理临床实践指南》，其中包括临床诊断、评估、治疗、管理和预防方面的建议。该协会上次于2014年发布的《慢性肝病肝性脑病临床实践指南》以及中华医学会肝病学分会于2018年发布的《肝硬化肝性脑病诊断和治疗指南》在术语、分级与分类、诊断、临床评估与治疗、管理和预防等方面存在一定差异和更新。在此，总结本指南的更新要点及其与我国指南的差异，以完善并理解新版指南对肝性脑病临床治疗的指导作用，为规范临床诊断和治疗提供帮助。
